Annual Cash & Cash Equivalents
$1.00
-$476.00-99.79%
September 30, 2024
Summary
- As of March 8, 2025, HQL annual cash & cash equivalents is $1.00, with the most recent change of -$476.00 (-99.79%) on September 30, 2024.
- During the last 3 years, HQL annual cash & cash equivalents has fallen by -$989.00 (-99.90%).
- HQL annual cash & cash equivalents is now -100.00% below its all-time high of $1.12 million, reached on September 30, 2019.
Performance
HQL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.00
NaN%
September 30, 2024
Summary
- As of March 8, 2025, HQL quarterly cash and cash equivalents is $1.00
- Over the past year, HQL quarterly cash and cash equivalents has dropped by -$476.00 (-99.79%).
- HQL quarterly cash and cash equivalents is now -100.00% below its all-time high of $292.40 thousand, reached on March 31, 2022.
Performance
HQL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HQL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -99.8% | -99.8% |
| 3 y3 years | -99.9% | -99.9% |
| 5 y5 years | -100.0% | - |
HQL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -99.9% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Tekla Life Sciences Investors Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $1.00(-99.8%) | $1.00(-99.8%) |
| Sep 2023 | $477.00(+7.2%) | $477.00(-42.0%) |
| Mar 2023 | - | $822.00(+84.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | $445.00(-55.1%) | $445.00(-99.8%) |
| Mar 2022 | - | $292.40 K(>+9900.0%) |
| Sep 2021 | $990.00(-99.9%) | $990.00 |
| Sep 2019 | $1.12 M | - |
FAQ
- What is Tekla Life Sciences Investors annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tekla Life Sciences Investors?
- What is Tekla Life Sciences Investors annual cash & cash equivalents year-on-year change?
- What is Tekla Life Sciences Investors quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tekla Life Sciences Investors?
- What is Tekla Life Sciences Investors quarterly cash and cash equivalents year-on-year change?
What is Tekla Life Sciences Investors annual cash & cash equivalents?
The current annual cash & cash equivalents of HQL is $1.00
What is the all time high annual cash & cash equivalents for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high annual cash & cash equivalents is $1.12 M
What is Tekla Life Sciences Investors annual cash & cash equivalents year-on-year change?
Over the past year, HQL annual cash & cash equivalents has changed by -$476.00 (-99.79%)
What is Tekla Life Sciences Investors quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HQL is $1.00
What is the all time high quarterly cash and cash equivalents for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high quarterly cash and cash equivalents is $292.40 K
What is Tekla Life Sciences Investors quarterly cash and cash equivalents year-on-year change?
Over the past year, HQL quarterly cash and cash equivalents has changed by -$476.00 (-99.79%)